The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 26 of the world's leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
World-renowned experts from NCCN Member Institutions diagnose and treat patients with a broad spectrum of cancers and are recognized for dealing with complex, aggressive, or rare cancers. NCCN Member Institutions pioneered the concept of the multidisciplinary team approach to patient care and conduct innovative research that contributes significantly to understanding, diagnosing, and treating cancer. NCCN programs offer access to expert physicians, superior treatment, and quality and safety initiatives that continuously improve the effectiveness and efficiency of cancer care.
Who We Are
An alliance of leading cancer centers devoted to patient care, research, and education
Why We Exist (Our Mission)
To improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives
To be the world’s leader in defining and advancing high-quality, high-value cancer care
Our Core Values
The NCCN Core Values represent the principles that we, the NCCN team, strive to embrace. As representatives of the world's leading cancer centers, we believe that by exemplifying these ideals within our organization, we can improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.
View the NCCN Core Values
View the NCCN Annual Report
View NCCN History
NCCN News includes all the latest announcements about NCCN programs, educational materials and upcoming events as well as helpful information for journalists. A complete listing of current and archived press releases, including NCCN Guidelines updates, announcements about the NCCN Oncology Research Program (ORP), and news at NCCN Member Institutions is easily accessible from the newsroom. Information and featured articles from NCCN eBulletin Newsletter, NCCN's electronic newsletter, can also be found in NCCN News.
NCCN’s Board of Directors is comprised of key leadership from each of the 26 NCCN Member Institutions, and the Board provides oversight for NCCN activities. The Chairman of the Board of Directors is Samuel M. Silver, MD, PhD, from the University of Michigan Comprehensive Cancer Center. The NCCN Chief Executive Officer is Robert W. Carlson, MD, who provides overall direction for the organization.
The NCCN Foundation is the philanthropic affiliate of NCCN embracing the NCCN mission of improving the quality, effectiveness, and efficiency of care provided to patients with cancer. The Chair of the Foundation Board of Directors is The Honorable Ellen O. Tauscher, former Under Secretary of State for Arms Control & International Security and
Member of Congress.
Organizations who are interested in supporting the NCCN Foundation®, are encouraged to contact Marcie Reeder, MPH, Executive Director, NCCN Foundation.
The NCCN Corporate Council is an important resource for the development and expansion of NCCN programs. NCCN gratefully acknowledges the support and commitment of these companies to the improvement of the treatments available to the patients whom we all serve. We also appreciate the recognition of NCCN's necessary autonomy in all decision-making regarding the conclusions, recommendations and outcomes of NCCN programs and resources.
NCCN is an Equal Opportunity Employer in a significant growth phase. If you would like to become part of our premier organization dedicated to developing programs and products to enhance cancer care, please see our employment opportunities. We offer competitive salaries and excellent benefits.
Organizations who are interested in supporting NCCN programs are encouraged to contact C. Lyn Fitzgerald, Senior Vice President, U.S. and Global Development .
Organizations who are interested in exhibiting at NCCN programs are encouraged to contact Jennifer Tredwell, Senior Director, Marketing.
Organizations who are interested in supporting NCCN CE programs are encouraged to contact Deborah Moonan, Director, Continuing Education and Grants.
Please go to our Permissions Requests Section to submit a request.
The National Comprehensive Cancer Network (NCCN) is a 501(c)3 not-for-profit alliance of 26 of the world’s leading cancer centers. All NCCN Member Institutions are not-for-profit organizations. NCCN and its Member Institutions are dedicated to improving the quality and effectiveness of care provided to patients with cancer. NCCN develops scientific, evaluative information to inform and improve decisions that can lead to better care. The development of NCCN information is based upon the independent evaluation of available scientific evidence integrated with the expert judgment of leading clinicians.
The NCCN Member Institutions are:
- Fred & Pamela Buffett Cancer Center, Omaha, NE
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
- City of Hope Comprehensive Cancer Center, Los Angeles, CA
- Dana-Farber/Brigham and Women’s Cancer Center
Massachusetts General Hospital Cancer Center, Boston, MA
- Duke Cancer Institute, Durham, NC
- Fox Chase Cancer Center, Philadelphia, PA
- Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
- Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
- Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ; Jacksonville, FL; and Rochester, MN
- Memorial Sloan Kettering Cancer Center, New York, NY
- Moffitt Cancer Center, Tampa, FL
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH
- Roswell Park Cancer Institute, Buffalo, NY
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO
- St. Jude Children's Research Hospital/The University of Tennessee Health Science Center, Memphis, TN
- Stanford Cancer Institute, Stanford, CA
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL
- UC San Diego Moores Cancer Center, La Jolla, CA
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
- University of Colorado Cancer Center, Aurora, CO
- University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
- The University of Texas MD Anderson Cancer Center, Houston, TX
- Vanderbilt-Ingram Cancer Center, Nashville, TN
- Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT